Screener
Lexeo Therapeutics, Inc. LXEO Q2 2026 earnings
Reported August 12, 2026 · Before market open
EPS-$0.30Miss by $0.01
EPS estimate-$0.29
Next report
Dec 14, 2026 (in 3 months)EPS estimate-$0.33
Versus estimates
Diluted EPS
FAQ
- When did Lexeo Therapeutics, Inc. report Q2 2026 earnings?
- Lexeo Therapeutics, Inc. (LXEO) reported Q2 2026 earnings on August 12, 2026 before market open.
- What were Lexeo Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Lexeo Therapeutics, Inc. reported eps of $-0.30 for Q2 2026.
- Did Lexeo Therapeutics, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.29 by $0.01.
- How did Lexeo Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 50.0% from $-0.60.
- Where can I find Lexeo Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-345722) and the 10-Q periodic report (0001193125-26-345724) directly on SEC EDGAR. The filing index links above go to sec.gov.
